Trial Details
COMPLETEDBasic Information
| Clinical ID | c1879 |
|---|---|
| Identifier | NCT02376478 |
| Trial Title | On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Psoriasis; Inflammatory Bowel Diseases |
| Interventions | DRUG: TNF-alpha inhibitors; DRUG: Alternative/no medication; OTHER: Alternative/no medication; DRUG: Purine/folic acid analogues |
Participant Information
| Sponsor | Medical University of Vienna |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-12-09 |
|---|---|
| Primary Completion Date | 2025-01-11 |
| Completion Date | 2025-01-11 |